|
1
|
Feuk L, Carson AR and Scherer SW:
Structural variation in the human genome. Nat Rev Genet. 7:85–97.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vogelstein B and Kinzler KW: Cancer genes
and the pathways they control. Nat Med. 10:789–799. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fearon ER and Vogelstein B: A genetic
model for colorectal tumorigenesis. Cell. 61:759–767. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Knudson AG: Cancer genetics. Am J Med
Genet. 111:96–102. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hoeijmakers JH: Genome maintenance
mechanisms for preventing cancer. Nature. 411:366–374. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li GM: Mechanisms and functions of DNA
mismatch repair. Cell Res. 18:85–98. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Motoyama N and Naka K: DNA damage tumor
suppressor genes and genomic instability. Curr Opin Genet Dev.
14:11–16. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Popova T, Manié E, Stoppa-Lyonnet D,
Rigaill G, Barillot E and Stern MH: Genome Alteration Print (GAP):
A tool to visualize and mine complex cancer genomic profiles
obtained by SNP arrays. Genome Biol. 10:R1282009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kondrashov AS and Rogozin IB: Context of
deletions and insertions in human coding sequences. Hum Mutat.
23:177–185. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang H, Zhong Y, Peng C, Chen JQ and Tian
D: Important role of indels in somatic mutations of human cancer
genes. BMC Med Genet. 11:1282010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gregory TR: Insertion-deletion biases and
the evolution of genome size. Gene. 324:15–34. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mwapagha LM: The role of viral sequences
in genetic aberrations and malignant transformation. University of
Cape Town, 2014. http://hdl.handle.net/11427/12870
|
|
13
|
Kasof GM, Goyal L and White E: Btf, a
novel death-promoting transcriptional repressor that interacts with
Bcl-2-related proteins. Mol Cell Biol. 19:4390–4404. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fulda S, Gorman AM, Hori O and Samali A:
Cellular stress responses: Cell survival and cell death. Int J Cell
Biol. 2010:2140742010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shen B, Tan M, Mu X, Qin Y, Zhang F, Liu Y
and Fan Y: Upregulated SMYD3 promotes bladder cancer progression by
targeting BCLAF1 and activating autophagy. Tumor Biol.
37:7371–7381. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee YY, Yu YB, Gunawardena HP, Xie L and
Chen X: BCLAF1 is a radiation-induced H2AX-interacting partner
involved in γH2AX-mediated regulation of apoptosis and DNA repair.
Cell Death Dis. 3:e3592012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lawrence MS, Stojanov P, Mermel CH,
Robinson JT, Garraway LA, Golub TR, Meyerson M, Gabriel SB, Lander
ES and Getz G: Discovery and saturation analysis of cancer genes
across 21 tumour types. Nature. 505:495–501. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Beroukhim R, Mermel CH, Porter D, Wei G,
Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J,
Urashima M, et al: The landscape of somatic copy-number alteration
across human cancers. Nature. 463:899–905. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu N, Clifford RJ, Yang HH, Wang C,
Goldstein AM, Ding T, Taylor PR and Lee MP: Genome wide analysis of
DNA copy number neutral loss of heterozygosity (CNNLOH) and its
relation to gene expression in esophageal squamous cell carcinoma.
BMC Genomics. 11:5762010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou X, Li X, Cheng Y, Wu W, Xie Z, Xi Q,
Han J, Wu G, Fang J and Feng Y: BCLAF1 and its splicing regulator
SRSF10 regulate the tumorigenic potential of colon cancer cells.
Nat Commun. 5:45812014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matejcic M, Mathew CG and Parker MI: The
relationship between environmental exposure and genetic
architecture of the 2q33 Locus with esophageal cancer in South
Africa. Front Genet. 10:4062019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kidd JM, Graves T, Newman TL, Fulton R,
Hayden HS, Malig M, Kallicki J, Kaul R, Wilson RK and Eichler EE: A
human genome structural variation sequencing resource reveals
insights into mutational mechanisms. Cell. 143:837–847. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
McLaren W, Pritchard B, Rios D, Chen Y,
Flicek P and Cunningham F: Deriving the consequences of genomic
variants with the Ensembl API and SNP effect predictor.
Bioinformatics. 26:2069–2070. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Becker KG, Barnes KC, Bright TJ and Wang
SA: The genetic association database. Nat Genet. 36:431–432. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tweedie S, Braschi B, Gray K, Jones TEM,
Seal RL, Yates B and Bruford EA: Genenames. org: The HGNC and VGNC
resources in 2021. Nucleic Acids Res. 49:D939–D946. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Namba M, Nishitani K and Kimoto T:
Characteristics of WI-38 cells (WI-38 CT-1) transformed by
treatment with Co-60 gamma rays. Gann. 71:300–307. 1980.PubMed/NCBI
|
|
27
|
Mwapagha LM, Tiffin N and Parker MI:
Delineation of the HPV11E6 and HPV18E6 pathways in initiating
cellular transformation. Front Oncol. 7:2582017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bailey JA, Yavor AM, Massa HF, Trask BJ
and Eichler EE: Segmental duplications: Organization and impact
within the current human genome project assembly. Genome Res.
11:1005–1017. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bailey JA, Gu Z, Clark RA, Reinert K,
Samonte RV, Schwartz S, Adams MD, Myers EW, Li PW and Eichler EE:
Recent segmental duplications in the human genome. Science.
297:1003–1007. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
DePristo MA, Banks E, Poplin R, Garimella
KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA,
Hanna M, et al: A framework for variation discovery and genotyping
using next-generation DNA sequencing data. Nat Genet. 43:491–498.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li H and Durbin R: Fast and accurate
long-read alignment with Burrows-Wheeler transform. Bioinformatics.
26:589–595. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu Q, Guo Y, Li J, Long J, Zhang B and
Shyr Y: Steps to ensure accuracy in genotype and SNP calling from
Illumina sequencing data. BMC Genomics. 13 (Suppl 8):S82012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guo Y, Zhao S, Sheng Q, Ye F, Li J,
Lehmann B, Pietenpol J, Samuels DC and Shyr Y: Multi-perspective
quality control of Illumina exome sequencing data using QC3.
Genomics. 103:323–328. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kato H, Arao T, Matsumoto K, Fujita Y,
Kimura H, Hayashi H, Nishiki K, Iwama M, Shiraishi O, Yasuda A, et
al: Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal
squamous cell carcinoma. Int J Oncol. 42:1151–1158. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vogelsang M, Paccez JD, Schäfer G, Dzobo
K, Zerbini LF and Parker MI: Aberrant methylation of the MSH3
promoter and distal enhancer in esophageal cancer patients exposed
to first-hand tobacco smoke. J Cancer Res Clin Oncol.
140:1825–1833. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sharma SV, Haber DA and Settleman J: Cell
line-based platforms to evaluate the therapeutic efficacy of
candidate anticancer agents. Nat Rev Cancer. 10:241–253. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mirabelli P, Coppola L and Salvatore M:
Cancer cell lines are useful model systems for medical research.
Cancers (Basel). 11:10982019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Borrell B: How accurate are cancer cell
lines? Nature. 463:8582010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Weinstein JN: Cell lines battle cancer.
Nature. 483:544–545. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gillet JP, Varma S and Gottesman MM: The
clinical relevance of cancer cell lines. J Natl Cancer Inst.
105:452–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bhowmick NA, Neilson EG and Moses HL:
Stromal fibroblasts in cancer initiation and progression. Nature.
432:332–337. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Boehm JS and Hahn WC: Immortalized cells
as experimental models to study cancer. Cytotechnology. 45:47–59.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Namba M, Nishitani K and Kimoto T: Effects
of theophylline on the cell growth of normal and malignant human
cells transformed in culture. Gann. 71:621–627. 1980.PubMed/NCBI
|
|
46
|
Itjima M, Mihara K, Kondo T, Tsuji T,
Ishioka C and Namba M: Mutation in p53 and de-regulation of
p53-related gene expression in three human cell lines immortalized
with 4-nitroquinoline 1-oxide or 60Co gamma rays. Int J Cancer.
66:698–702. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Rhim JS, Yoo JH, Park JH, Thraves P,
Salehi Z and Dritschilo A: Evidence for the multistep nature of in
vitro human epithelial cell carcinogenesis. Cancer Res. 50 (Suppl
17):5653S–5657S. 1990.PubMed/NCBI
|
|
48
|
Yoon S, Xuan Z, Makarov V, Ye K and Sebat
J: Sensitive and accurate detection of copy number variants using
read depth of coverage. Genome Res. 19:1586–1592. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sims D, Sudbery I, Ilott NE, Heger A and
Ponting CP: Sequencing depth and coverage: Key considerations in
genomic analyses. Nat Rev Genet. 15:121–132. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Iafrate AJ, Feuk L, Rivera MN, Listewnik
ML, Donahoe PK, Qi Y, Scherer SW and Lee C: Detection of
large-scale variation in the human genome. Nat Genet. 36:949–951.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ungerbäck J, Belenki D, Jawad ul-Hassan A,
Fredrikson M, Fransén K, Elander N, Verma D and Söderkvist P:
Genetic variation and alterations of genes involved in
NFκB/TNFAIP3-and NLRP3-inflammasome signaling affect susceptibility
and outcome of colorectal cancer. Carcinogenesis. 33:2126–2134.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kuwano H, Kato H, Miyazaki T, Fukuchi M,
Masuda N, Nakajima M, Fukai Y, Sohda M, Kimura H and Faried A:
Genetic alterations in esophageal cancer. Surg Today. 35:7–18.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Han CL, Liao CS, Wu CW, Hwong CL, Lee AR
and Yin SJ: Contribution to first-pass metabolism of ethanol and
inhibition by ethanol for retinol oxidation in human alcohol
dehydrogenase family. Eur J Biochem. 254:25–31. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Hanawa M, Suzuki S, Dobashi Y, Yamane T,
Kono K, Enomoto N and Ooi A: EGFR protein overexpression and gene
amplification in squamous cell carcinomas of the esophagus. Int J
Cancer. 118:1173–1180. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Guo M, Liu S, Herman JG, Zhuang H and Lu
F: Brief communication Gefitinib-sensitizing mutation in esophageal
carcinoma cell line Kyse450. Cancer Biol Ther. 5:152–155. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Vogelsang M, Wang Y, Veber N, Mwapagha LM
and Parker MI: The cumulative effects of polymorphisms in the DNA
mismatch repair genes and tobacco smoking in oesophageal cancer
risk. PLoS One. 7:e369622012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Shao AW, Sun H, Geng Y, Peng Q, Wang P,
Chen J, Xiong T, Cao R and Tang J: Bclaf1 is an important NF-κB
signaling transducer and C/EBPβ regulator in DNA damage-induced
senescence. Cell Death Differ. 23:865–875. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wen Y, Zhou X, Lu M, He M, Tian Y, Liu L,
Wang M, Tan W, Deng Y, Yang X, et al: Bclaf1 promotes angiogenesis
by regulating HIF-1α transcription in hepatocellular carcinoma.
Oncogene. 38:1845–1859. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Dell'Aversana C, Giorgio C, D'amato L,
Lania G, Matarese F, Saeed S, Di Costanzo A, Belsito Petrizzi V,
Ingenito C, Martens JHA, et al: miR-194-5p/BCLAF1 deregulation in
AML tumorigenesis. Leukemia. 31:2315–2325. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Jiang T, Liu B, Wu D and Zhang F: BCLAF1
induces cisplatin resistance in lung cancer cells. Oncol Lett.
20:2272020. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wang H, Liang L, Fang J-Y and Xu J:
Somatic gene copy number alterations in colorectal cancer: New
quest for cancer drivers and biomarkers. Oncogene. 35:2011–2019.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Liu H, Lu ZG, Miki Y and Yoshida K:
Protein kinase C delta induces transcription of the TP53 tumor
suppressor gene by controlling death-promoting factor Btf in the
apoptotic response to DNA damage. Mol Cell Biol. 27:8480–8491.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lin DC, Hao JJ, Nagata Y, Xu L, Shang L,
Meng X, Sato Y, Okuno Y, Varela AM, Ding LW, et al: Genomic and
molecular characterization of esophageal squamous cell carcinoma.
Nat Genet. 46:467–473. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Song Y, Li L, Ou Y, Gao Z, Li E, Li X,
Zhang W, Wang J, Xu L, Zhou Y, et al: Identification of genomic
alterations in oesophageal squamous cell cancer. Nature. 509:91–95.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Savage KI, Gorski JJ, Barros EM, Irwin GW,
Manti L, Powell AJ, Pellagatti A, Lukashchuk N, McCance DJ,
McCluggage WG, et al: Identification of a BRCA1-mRNA splicing
complex required for efficient DNA repair and maintenance of
genomic stability. Mol Cell. 54:445–459. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Dietlein F, Thelen L and Reinhardt HC:
Cancer-specific defects in DNA repair pathways as targets for
personalized therapeutic approaches. Trends Genet. 30:326–339.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Friedberg EC: DNA damage and repair.
Nature. 421:436–440. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Leung J, Ehmann G, Giangrande P and Nevins
J: A role for Myc in facilitating transcription activation by E2F1.
Oncogene. 27:4172–4179. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Muthuswami M, Ramesh V, Banerjee S, Viveka
Thangaraj S, Periasamy J, Bhaskar Rao D, Barnabas GD, Raghavan S
and Ganesan K: Breast tumors with elevated expression of 1q
candidate genes confer poor clinical outcome and sensitivity to
Ras/PI3K inhibition. PLoS One. 8:e775532013. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Vermeulen K, Van Bockstaele DR and
Berneman ZN: The cell cycle: A review of regulation, deregulation
and therapeutic targets in cancer. Cell Prolif. 36:131–149. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Bertoli C, Skotheim JM and De Bruin RA:
Control of cell cycle transcription during G1 and S phases. Nat Rev
Mol Cell Biol. 14:518–828. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Kruse JP and Gu W: Modes of p53
regulation. Cell. 137:609–622. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Riedl SJ and Shi Y: Molecular mechanisms
of caspase regulation during apoptosis. Nat Rev Mol Cell Biol.
5:897–904. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Thomadaki H and Scorilas A: BCL2 family of
apoptosis-related genes: Functions and clinical implications in
cancer. Crit Rev Clin Lab Sci. 43:1–67. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Cory S and Adams JM: The Bcl2 family:
Regulators of the cellular life-or-death switch. Nat Rev Cancer.
2:647–656. 2002. View
Article : Google Scholar : PubMed/NCBI
|
